Dallas, TX – January 29, 2020 - Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC PINK: KALY) (“KALY”) today confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY’s proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions. The formulation for the treatment of symptoms associated with COPD and other...

read more